GRFS Grifols, S.A. Full Business Value
Grifols, S.A. (GRFS) dominates the plasma-derived medicines segment thanks to an extensive network of collection centers that creates a barrier to entry for competitors. This price chart illustrates the enterprise value, which currently stands at 14025.35. Robotic packaging and fractionation lines, which eliminate manual labor, enhance business efficiency. Meanwhile, the company is stabilizing plasma collection profitability while simultaneously addressing debt issues and management restructuring.
Grifols, S.A. (GRFS) - metric breakdowns and financial figures
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:Grifols SA (GRFS)
Fundamental asset selection requires an analysis of the total business value, excluding market noise. Enterprise Value sums market capitalization and debt minus cash, which is critical for Grifols, S.A. (GRFS), whose margins are constrained by inflation in plasma procurement costs; by tracking the enterprise value on the GURU.Markets chart, an investor sees the real buyout price of the company accounting for its debt load.
Competitor analysis for Grifols, S.A.
Value Adjusted for Debt and Cash argenx N.V. ARGX|Enterprise Value BioNTech Group|ABVX: Full Business Value|ADMA Biologics - Total Company Value|PTGX (protagonist-inc.com) - Company Buyout Price|Total Company Value Immunovant IMVT|Full Business Value Kiniksa Pharmaceuticals, Ltd.|Adaptive Biotechnologies Corp (ADPT) - Enterprise Value|Value Adjusted for Debt and Cash Celldex Corp (CLDX)|Enterprise Value AUPH (Aurinia Pharmaceuticals)|biocryst.com - Enterprise Value|Total Company Value Vera Therapeutics (VERA)|DNTH: Value Adjusted for Debt and Cash|PHVS (Pharvaris Corp) - Total Company Value|AbCellera Biologics Inc. (ABCL) - Real Price to Acquire Entire Company|TRML (Tourmaline Bio, Inc.) - Enterprise Value|Enterprise Value precigen.com (PGEN)|Pharming Group (PHAR) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Nektar Therapeutics Inc (NKTR)|Enterprise Value UPB|Zenas Corp - Company Buyout Price|IMNM: Total Company Value|GOSS: Real Price to Acquire Entire Company|KALV (KalVista Pharmaceuticals, Inc.) - Total Company Value|Real Price to Acquire Entire Company Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Real Price to Acquire Entire Company|Enterprise Value SVRA|Total Company Value Rigel Pharmaceuticals RIGL|Business Value anaptysbio.com (ANAB)|ATXS: Enterprise Value|Total Enterprise Value enGene Holdings Inc ENGN|Enterprise Value RAPT|JBIO: Full Takeover Company Value|Total Company Value Aclaris Therapeutics ACRS|kyvernatx.com (KYTX) - Value Adjusted for Debt and Cash|TLSA: Enterprise Value|Company Buyout Price Cabaletta Bio Inc.|VTYX - Enterprise Value|Full Business Value THTX (Theratechnologies, Inc)|AVTX: Total Company Value|eledon.com - Total Enterprise Value|AGEN - Total Company Value|CLYM: Total Company Value|Zura Bio - Total Company Value|Company Buyout Price aTyr Pharmaceuticals|ADAG - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash IMA|STTK (Shattuck Labs, Inc.) - Total Company Value|Company Buyout Price equilliumbio.com EQ|Real Price to Acquire Entire Company CNTB|Company Buyout Price Immunic Therapeutics IMUX|Atara Biotherapeutics Inc - Enterprise Value|InflaRx N.V. (IFRX) - Enterprise Value|X4 Pharmaceuticals, Inc. - Real Price to Acquire Entire Company|Adicet Bio, Inc. (ACET) - Company Buyout Price|Celularity Inc - Enterprise Value|Full Takeover Company Value INMB|Barinthus Biotherapeutics (BRNS) - Total Company Value|Value Adjusted for Debt and Cash kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. (SABS) - Enterprise Value|Akari Therapeutics PLC - Full Business Value|Total Company Value ENLV (Enlivex Therapeutics, Ltd.)|QTTB: Company Buyout Price|Total Company Value GeoVax Labs, Inc. (GOVX)|edesabiotech.com (EDSA) - Full Business Value|IBIO - Enterprise Value|Value Adjusted for Debt and Cash Carisma Tx|Enterprise Value XTLB|Enterprise Value BOLT (boltbio.com)|Total Company Value HCW Biologics|Aptevo Therapeutics, Inc. - Value Adjusted for Debt and Cash|AIM: Total Company Value|ADTX - Real Price to Acquire Entire Company|GRI: Enterprise Value|Enterprise Value XORTX Corp|HIND - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash revbiosciences.com|INDP (Indaptus Therapeutics, Inc.) - Enterprise Value|Company Buyout Price SCNI (Scinai Immunotherapeutics Ltd)|CalciMedica - Total Company Value|Affimed NV - Real Price to Acquire Entire Company|ALLK: Total Company Value|HOOKIPA Pharma Inc. (HOOK) - Real Price to Acquire Entire Company|IGMS: Real Price to Acquire Entire Company|ITOS (iTeos Therapeutics Inc) - Enterprise Value|Total Company Value Ocean Bio (OCEA)|Business Value TC BioPharm Ltd|Third Harmonic Bio - Enterprise Value